Abstract
The consumption of soybeans and their constituents, isolated soy protein and isoflavones, has been associated with positive effects on body weight, lipid profile and insulin, which has stimulated the production and consumption of foods derived from soy. However, these polyphenolic compounds (isoflavones) have similar structure to 17-beta estradiol and may act as agonists or antagonists in estrogen receptors. Due to its estrogenic activity, the safety of its consumption during critical periods of development, such as gestation and lactation, has been questioned. Studies that evaluate the effects of soybeans on endocrine metabolic parameters are still controversial. This review focuses on the role that soy and isoflavones play during critical periods of development and into adulthood. J Endocrinol Metab. 2017;7(5):135-140 doi: https://doi.org/10.14740/jem449w
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
